v3.26.3
Condensed Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (4,695,299) $ (1,195,560) $ (3,847,637) $ (4,855,405)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 2,317 2,317 4,634 6,300
Stock-based compensation 107,425 102,698 1,353,489 269,669
Amortization of right-of-use asset 58,871 57,277 115,342 112,294
Issuance of common stock for professional services 2,434,080      
Realized loss on sale of investment     722
Amortization of purchase discounts on investments     (66,521)
Changes in operating assets and liabilities:        
Prepaid expenses and other assets (191,225) 40,262 24,309 (2,794)
Accounts payable (215,099) (86,945) 214,574 (332,599)
Accrued expenses and other current liabilities 57,493 197,412 202,231 (753,966)
Accrued interest - related parties 46,438 25,264 100,881 5,000
Operating lease liability (58,722) (55,368) (112,521) (106,022)
Net cash used in operating activities (2,453,721) (912,643) (1,944,698) (5,723,322)
Cash flows from investing activities:        
Purchases of investments (2,000,000) (4,333,688)
Proceeds from sale of investment     585,198
Proceeds from maturities of investments     7,675,000
Purchase of property and equipment     (1,846)
Net cash used in investing activities (2,000,000) 3,924,664
Cash flows from financing activities:        
Proceeds from issuance of Series C Convertible Preferred Stock, net of issuance costs of $697,905 6,802,095    
Proceeds from notes payable - related parties 168,158 1,500,000    
Proceeds from notes payable – other 30,000    
Repayment of notes payable - related parties (168,158)    
Repayment of notes payable - other (30,000)    
Repurchase of stock     (50,000)
Proceeds from notes payable – related parties     1,500,000
Net cash provided by financing activities 6,802,095 1,500,000 1,500,000 (50,000)
Net increase (decrease) in cash and cash equivalents 2,348,374 587,357 (444,698) (1,848,658)
Cash and cash equivalents - beginning of period 236,400 681,098 681,098 2,529,756
Cash and cash equivalents - end of period 2,584,774 1,268,455 236,400 681,098
Cash paid during the six months ended for:        
Interest 2,409    
Non-cash investing and financing activities:        
Conversion of convertible notes payable into common stock 1,500,000    
Conversion of convertible notes payable accrued interest into common stock $ 147,319    
Non-cash investing and financing activities:        
Common stock issued to board members for settlement of accrued board fees     120,000 144,000
Conversion of principal on notes payable – related party for common stock     200,000
Forgiveness of accrued interest on notes payable – related party     $ 143,020